IP from Gilger laboratory part of New Company (Tamid Bio)

Fortress Biosciences announced today that they are forming Tambid Bio, a new company to develop IP generated and licensed from Dr. Gilger’s (NCSU) and Dr. Matt Hirsch’s (UNC) labs.  These exciting new gene therapies will revolutionize the treatment of corneal disease!

See press release: http://ir.fortressbiotech.com/Cache/1500105881.PDF?O=PDF&T=&Y=&D=&FID=1500105881&iid=4308955